There are a variety of ways in which we can work together:
Advertising
Sponsored Papers
Submit Manuscripts
Supplements
The attraction of Current Oncology is increasing for Canadian Oncologists, Oncologists internationally, and family doctors involved in cancer therapy. This is underscored by our entry into PubMed, which is highly selective with its journals. The strength of the physicians and scientists on the journal Board add to the prominence of Current Oncology and put in place those individuals who can peer review articles for both the regular issues, as well as the published supplements.
Develop each and every one of your launches with Current Oncology to disseminate the information about your product through a credible, well read, academic, peer reviewed journal, Current Oncology. As well as giving the Oncology community a thorough understanding of your new product, you will also receive the exposure you are seeking, making your product a very visible one in the Oncology market. Please note, this initiative can be accessed at any time during the advertising life of your bioceutical.
Print advertisements can be placed in our regular issues, supplements, or reprints. The various forms of ads that we accept include graphic-based ads, advertorials, and sponsored ads appearing in special sections. They can be placed in regular issues, supplements, and reprints. Your company can also place banner advertisements on our website for an annual fee; these ads appear on the bottom of every page.
For pricing information and more detail about advertising in our journal, click here.
Sponsored articles in Current Oncology represent an easy and visible way to position your company alongside medical leadership as well as editorial excellence. Bringing targeted exposure for your company and product, a sponsored paper provides a platform to introduce new concepts or to reinforce current concepts directly into the hands of your key audience. Sponsored articles provide the opportunity to present your organization as a major provider of up-to-date, and valuable educational material that can be customized to your needs.
Pharmaceutical Company to contribute:
- Suggestions of authors
- Topics for the articles
- Reading of articles/supplements before peer review
- Final sign off of manuscript before publishing
Current Oncology Team to deliver:
- Liaising with the suggested authors
- Peer reviewing submitted manuscripts
- Distribution of the manuscript to Current Oncology’s circulation, or any requested circulation, through a regular or supplemental issue of Current Oncology
Price is determined by size of manuscripts, generally $1,500.00 per page. Click here to view a sample contract for sponsored articles.
It is your company’s choice whether you would like your logo to appear on the articles, or to be acknowledged with “this article is brought to you by an unrestricted grant by…”.
Click here for further information about sponsored papers with Current Oncology.
Multimed Inc. may publish your articles back to back, either in the same issue or in sequential issues, of the basic science underlying the development of a product, followed by the clinical outcomes of the trials that subsequently followed. Current Oncology is distributed to all of the Oncologists in Canada and to an increasing number in the U. S. A. We are also presently looking at other disciplines for distribution. In addition, Current Oncology is now indexed on PubMed, Journal Selector and other databases, causing researchers and Oncologists to search these avenues for information in their areas of interest. This will further broaden the spectrum of clinicians that we reach, who look for specific articles in the literature.
A number of other possibilities are now being considered such as a "Case of the Month" which would be written by someone of your choice, in consultation with the Deputy Editors of the journal. Such an article would highlight a particular drug that had been successfully employed for the patient under consideration. In addition, we remain open to other possibilities that might come to mind for our particular needs. We are certainly ready to work with you to develop and tailor such initiatives.
Current Oncology's attraction is further highlighted by our involvement and relationships within the patient community. Not only do we realize how important a relationship is with these groups, but we have worked and will continue to work in tandem with them in creating our patient education supplements.
Publication of a Supplement with Current Oncology will carry the logo of the journal, a logo or bi-line of the sponsoring company and the outstanding names of the Scientific and Clinical Board Members of the journal. Your company will work directly with our editorial team, advertising reprsentative and marketing coordinator, to produce and publish your supplement.
Professional Supplements will be distributed to all of the Oncologists in the country, all of the family physicians who are involved in Oncology, and an expanding market in the U.S.A. A great many of these individuals are members of the Canadian Association of General Practitioners in Oncology (CAPGO).
Patient Education Supplements will be distributed to patients and their families who are concerned about a tumor of a particular type. This would be done through the various cancer associations in the country (breast, large bowel, etc). This distribution includes our circulaton, as well as any type of mailing list provided by your company.
Proposal:
Step 1: Scientific Review of the product. How it came to be? The education behind the product, why it was brought to the market.
Step 2: Reporting of results of clinical trials for the specific product, as well as any initial problems with the product.
Step 3: A larger group of articles, encompassed in a freestanding supplement, directed at the professional Oncology community.
Click here to view a sample professional supplement contract.
Step 4: A patient education supplement with information about your product with easy to understand language intended for oncology patients.
For further information about supplements, including the stages of creating a supplement click here.
*Advertisement for Current Oncology
Current Oncology. ISSN: 1198-0052
Last Updated: 04/02/08